Manipal Health Enterprises opened its initial public offering for subscription on July 29 to raise ₹8,000 crore [1].

The offering represents a significant capital injection for the healthcare sector in India. By tapping into both domestic and global institutional investment, the company aims to scale its operational capacity and market presence.

The company set a price band of ₹560 to ₹590 per share [1]. According to reporting from MSN, the issue was 45% booked as of the third day of the subscription period [2]. Other reports indicated the issue had been booked 74% [1].

Manipal Health Enterprises is seeking significant backing from a mix of global and domestic institutional investors [2]. This strategic move is designed to solidify the company's financial position as it expands its healthcare infrastructure.

The subscription process began late last month. Allotment for the shares is expected on August 3, with the official market debut scheduled for August 5 [1, 2].

Investors are currently monitoring the grey market premium and key dates to determine the potential performance of the stock upon its listing. The company's ability to reach its ₹8,000 crore goal [1] will depend on the final subscription levels from retail and institutional buyers.

“Manipal Health Enterprises IPO opened for subscription on July 29, with a price band of ₹560–590 per share.”

The scale of this IPO reflects a broader trend of healthcare privatization and expansion in India. A successful raise of ₹8,000 crore would provide Manipal Health Enterprises with the liquidity needed to compete with other major hospital chains, potentially increasing the availability of high-end medical services while signaling strong investor confidence in the Indian private health market.